Probing the Interactome of Corticotropin-Releasing Factor Receptor Heteromers Using Mass Spectrometry.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 11 4 2019
pubmed: 11 4 2019
medline: 3 8 2019
Statut: ppublish

Résumé

Mass spectrometry is a sensitive technique used in the field of proteomics that allows for simultaneous detection and characterization of several proteins in a sample. It is also a powerful methodology to elucidate protein-protein interactions in a sequence-dependent and unbiased manner. G protein-coupled receptors (GPCRs) seldom function in isolation and characterization of proteins present in the receptor complex (or its interactome) is critical for understanding the vast spectrum of functions these receptors perform in a context-dependent manner. Here, we describe a mass spectrometry-based method to sequence and characterize proteins present in heteromeric complexes formed by corticotropin-releasing factor (CRF) receptors that belong to class B GPCRs. CRF receptor heteromeric complexes were identified in HEK293 cells co-transfected with tagged CRF receptors 1 and 2. CRF receptors were immunoprecipitated using antibodies against the tags from transfected HEK293 cells and proteins in their interactome were identified using liquid chromatography mass spectrometry method (LC-MS/MS). Both CRF receptors were identified in this interactome. A few of the proteins identified in the CRF receptor interactome using MS were confirmed to be true interactions using traditional co-immunoprecipitation and Western blotting methods.

Identifiants

pubmed: 30969422
doi: 10.1007/978-1-4939-9121-1_15
doi:

Substances chimiques

Receptors, Corticotropin-Releasing Hormone 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Pagination

269-285

Subventions

Organisme : NIGMS NIH HHS
ID : P41 GM103481
Pays : United States
Organisme : NCCIH NIH HHS
ID : T32 AT003997
Pays : United States

Auteurs

Burcu Hasdemir (B)

The Osher Center for Integrative Medicine, University of California, San Francisco, San Francisco, CA, USA.
Department of Ob-Gyn, University of California, San Francisco, San Francisco, CA, USA.

Juan A Oses-Prieto (JA)

Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.

Alma Burlingame (A)

Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.

Aditi Bhargava (A)

The Osher Center for Integrative Medicine, University of California, San Francisco, San Francisco, CA, USA. aditi.bhargava@ucsf.edu.
Department of Ob-Gyn, University of California, San Francisco, San Francisco, CA, USA. aditi.bhargava@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH